Home Cart 0 Sign in  
X

[ CAS No. 222978-01-0 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 222978-01-0
Chemical Structure| 222978-01-0
Chemical Structure| 222978-01-0
Structure of 222978-01-0 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 222978-01-0 ]

Related Doc. of [ 222978-01-0 ]

Alternatived Products of [ 222978-01-0 ]

Product Details of [ 222978-01-0 ]

CAS No. :222978-01-0 MDL No. :MFCD08236860
Formula : C7H6BrFO Boiling Point : -
Linear Structure Formula :- InChI Key :VQDUFYPJCUBGQW-UHFFFAOYSA-N
M.W : 205.02 Pubchem ID :20682297
Synonyms :

Calculated chemistry of [ 222978-01-0 ]

Physicochemical Properties

Num. heavy atoms : 10
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.14
Num. rotatable bonds : 1
Num. H-bond acceptors : 2.0
Num. H-bond donors : 1.0
Molar Refractivity : 40.23
TPSA : 20.23 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.25 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.89
Log Po/w (XLOGP3) : 1.83
Log Po/w (WLOGP) : 2.35
Log Po/w (MLOGP) : 2.72
Log Po/w (SILICOS-IT) : 2.77
Consensus Log Po/w : 2.31

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.64
Solubility : 0.467 mg/ml ; 0.00228 mol/l
Class : Soluble
Log S (Ali) : -1.88
Solubility : 2.73 mg/ml ; 0.0133 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -3.36
Solubility : 0.0887 mg/ml ; 0.000433 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.39

Safety of [ 222978-01-0 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 222978-01-0 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 222978-01-0 ]
  • Downstream synthetic route of [ 222978-01-0 ]

[ 222978-01-0 ] Synthesis Path-Upstream   1~18

  • 1
  • [ 222978-01-0 ]
  • [ 57848-46-1 ]
YieldReaction ConditionsOperation in experiment
63% With sodium acetate; pyridinium chlorochromate In dichloromethane at 20℃; for 2 h; To a solution of (4-bromo-3-fluoro-phenyl)-methanol (7.9 g, 38.5 mmol) in dichloromethane (160.0 mL) was added sodium acetate (940 mg, 11.5 mmol) followed by pyridinium chlorochromate (10.8 g, 50.0 mmol) at room temperature. The reaction mixture was stirred at room temperature under light protection over a period of 2 h. The resulting reaction mixture was diluted with ethyl acetate (1.0 L) and filtered through celite pad. The filtrate obtained was washed with aqueous sodium bicarbonate (600 mL), water (600 mL) and dried over sodium sulphate. The crude product obtained upon evaporation of the solvent was further purified by column chromatography to give 4-bromo-2-fiuoro- benzaldehyde as white solid (5.0 g, 63percent).
63% With sodium acetate; pyridinium chlorochromate In dichloromethane at 20℃; for 2 h; light protection To a solution of (4-bromo-3-fluoro-phenyl)-methanol (7.9 g, 38.5 mmol) in dichloromethane (160.0 mL) was added sodium acetate (940 mg, 11.5 mmol) followed by pyridinium chlorochromate (10.8 g, 50.0 mmol) at room temperature.
The reaction mixture was stirred at room temperature under light protection over a period of 2 h.
The resulting reaction mixture was diluted with ethyl acetate (1.0 L) and filtered through celite pad.
The filtrate obtained was washed with aqueous sodium bicarbonate (600 mL), water (600 mL) and dried over sodium sulphate.
The crude product obtained upon evaporation of the solvent was further purified by column chromatography to give 4-bromo-2-fluoro-benzaldehyde as white solid (5.0 g, 63percent).
Reference: [1] Patent: WO2011/21209, 2011, A1, . Location in patent: Page/Page column 38; 39
[2] Patent: US2012/101099, 2012, A1, . Location in patent: Page/Page column 13; 14
  • 2
  • [ 222978-01-0 ]
  • [ 222978-03-2 ]
Reference: [1] Journal of Medicinal Chemistry, 2003, vol. 46, # 14, p. 2973 - 2984
[2] Bioorganic and Medicinal Chemistry Letters, 2001, vol. 11, # 10, p. 1257 - 1260
  • 3
  • [ 153556-42-4 ]
  • [ 222978-01-0 ]
YieldReaction ConditionsOperation in experiment
94% With borane-THF In tetrahydrofuran at 25℃; General procedure: BH3.THF (89 mL, 89.49 mmol) was added dropwise to a stirred solution of 4-bromo-3-fluorobenzoic acid (9.8 g, 44.75 mmol) in THF (200 mL) at 25°C, over a period of 10 minutes under nitrogen. The resulting solution was stirred at ambient temperaturefor 2 days. The reaction mixture was cautiously quenched with 2M Na2CO3 (200 mL),extracted with Et2O (2 x 500 mL), the organic extratcts were combined, washed with saturated brine (400 mL), dried over MgSO4, filtered and evaporated to afford a paleyellow oil. The crude product was purified by flash silica chromatography, elution gradient 0 to 70percent EtOAc in heptane. Pure fractions were evaporated to dryness to afford (4-bromo-3-fluorophenyl)methanol (8.65 g, 94 percent) as a white solid.
93%
Stage #1: With borane In tetrahydrofuran at 0 - 70℃;
Stage #2: With hydrogenchloride In methanol; water at 25℃; for 2 h;
To a solution of commercially available 4-bromo-3-fluoro-benzoic acid (SI-2) (11 g, 50 mmol) in THF (250 mL) was added BH3 (1.0 M in THF, 100 mL, 100 mmol) at 0 oC and then the solution was stirred at 70 oC overnight. Then, the mixture was quenched with MeOH and 1 N HCl, and stirred at room temperature for an additional 2 hours. The mixture was extracted with EtOAc and the organic layer was washed with brine, dried over anhydrous Na2SO4, filtered and concentrated to give the crude product which was purified by column chromatography to obtainSI-3 (9.5 g, 93percent) as a yellow oil.ESI-MS m/z 205 [M+H]+calc. forC7H6BrFO.This intermediate was used in the next step without further characterization.
91.6% With dimethylsulfide borane complex In tetrahydrofuran; diethyl ether at 0 - 20℃; for 6 h; Step 1 (MT-Si):Boranmethyl sulfide in ether (5.0 M; 38.3 mL, 191.8 mmol) was added to a solution of 4- bromo-3-fluorobenzoic acid (21.0 g, 95.9 mmol) in dry tetrahydrofuran (250 mL) at 0°C and the reaction mixture was stirred at room temperature for 6 h. The reaction was quenched with saturated sodium hydrogen carbonate solution, extracted with ethyl acetate, and the combined organic layers were washed with water, brine; dried over anhydrous sodium sulfate and filtered. The solvent was evaporated under vacuum to afford 18 g (91 .6percent) of MTSi as a colorless liquid, further used without any purification.
87% With borane-THF In tetrahydrofuran at 0 - 20℃; for 72 h; Step A: (4-Bromo-3-fluorophenyl methanolA 0°C solution of 4-bromo-3-fluoro benzoic acid (2.3 g, 10.50 mmol) in dry THF (52.5 ml) is treated with borane tetrahydrofuran complex (15.75 ml of a 1 M solution in THF, 15.75 mmol) and the resulting mixture stirred at RT for 72 hours. The mixture is then quenched with IN HC1, stirred for 20 minutes, then extracted with DCM. Concentration and silica gel chromatography (10-50percent EtOAc/hexanes) yields the title compound 1.87 g (87 percent yield) as colorless needles. 1H NMR (500 MHz, CDC13) δ 7.55 (m, IH), 7.04 (d, J9.4 Hz, IH), 7.04 (d, J 8.3 Hz, IH), 4.70 (d, 2H).
87% With borane-THF In tetrahydrofuran at 20℃; for 72 h; A ooc solution of 4-bromo-3-fluoro benzoic acid (2.3 g, 10.50 mmol) in dry THF (52.5ml) is treated with borane tetrahydrofuran complex (15.75 ml of a 1M solution in THF, 15.75mmol) and the resulting mixture stirred at RT for 72 hours. The mixture is then quenched with20 IN HCl, stirred for 20 minutes, then extracted with DCM. Concentration and silica gelchromatography (10-50percent EtOAc/hexanes) yields the title compound 1.87 g (87percent yield) ascolorless needles. 1H NMR (500 MHz, CDCh) 8 7.55 (m, IH), 7.04 (d, J9.4 Hz, IH), 7.04 (d, J8.3 Hz, IH), 4.70 (d, 2H).
84%
Stage #1: With sodium tetrahydroborate; boron trifluoride diethyl etherate In tetrahydrofuran at 20℃; for 2 h;
Stage #2: With methanol In tetrahydrofuran
To a suspension of sodium borohydride (10.4 g, 0.27 mol) in tetrahydrofuran (200 mL) was added boron trifluoride etherate (44.3 mL, 0.36 mol) followed by 4-bromo-3- fluoro-benzoic acid (10.0 g, 0.04 mol) in THF (200 mL) at ice temperature. The mixture was allowed to stir at room temperature over a period of 2 h. The resulting reaction mixture was quenched with methanol and methanol was removed under reduced pressure. The residue obtained upon evaporation of methanol was diluted with ethyl acetate (1.0 L), washed with water (700 mL), dried over sodium sulphate and concentrated to give (4- bromo-3-fluoro-phenyl)-methanol as off-white solid (7.9 g, 84percent)
84%
Stage #1: With sodium tetrahydroborate; boron trifluoride diethyl etherate In tetrahydrofuran at 20℃; for 2 h; Cooling with ice
Stage #2: With water In ethyl acetate
To a suspension of sodium borohydride (10.4 g, 0.27 mol) in tetrahydrofuran (200 mL) was added boron trifluoride etherate (44.3 mL, 0.36 mol) followed by 4-bromo-3-fluoro-benzoic acid (10.0 g, 0.04 mol) in THF (200 mL) at ice temperature.
The mixture was allowed to stir at room temperature over a period of 2 h.
The resulting reaction mixture was quenched with methanol and methanol was removed under reduced pressure.
The residue obtained upon evaporation of methanol was diluted with ethyl acetate (1.0 L), washed with water (700 mL), dried over sodium sulphate and concentrated to give (4-bromo-3-fluoro-phenyl)-methanol as off-white solid (7.9 g, 84percent).
73%
Stage #1: With sodium tetrahydroborate In tetrahydrofuran for 0.666667 h; Inert atmosphere
Stage #2: With iodine In tetrahydrofuran at 20℃; for 14.5833 h; Cooling with ice
A suspension of 4-bromo-3-fluorobenzoic acid (84) (1.61 g, 7.35 mmol) in anhydrous THF (10 mL, then 4x 3 mL to rinse) under N2 was added drop- wise (over 40 min) to a suspension of sodium borohydride (400 mg, 10.6 mmol) in anhydrous TIIF (15 mL) under N2, and then the mixture was cooled in an ice bath. A solution of iodine (1.008 g, 3.97 mmol) in anhydrous THF (10 mL, then 2x 3 mL) was added drop- wise (over 35 min) to the stirred solution and then the mixture was stirred at room temperature for 14 h. The mixture was concentrated under reduced pressure and then treated successively with water (20 mL), 10percent HCl (3.4 mL) and water (20 mL), and extracted with CH2Cl2 (4x 50 mL). The extracts were evaporated to dryness and the residue was chromatographed on silica gel, eluting with 50percent CH2Cl2/petroleum ether, to give (4-bromo-3-fluorophenyl)methanol (85) (1.096 g, 73percent) as a white solid: mp (CH2Cl2/petroleum ether) 39-40 °C; 1H NMR (CDCl3) δ 7.52 (dd, J = 8.0, 7.2 Hz, 1 H), 7.16 (dd, J = 9.3, 1.8 Hz, 1 H), 7.02 (dd, J = 8.2, 1.8 Hz, 1 H), 4.67 (d, J = 5.9 Hz, 2 H), 1.75 (t, J = 5.9 Hz, 1 H); HREIMS calcd for C7H6BrFO mlz (M+) 205.9567, 203.9586, found 205.9566, 203.9580.
73%
Stage #1: With sodium tetrahydroborate In tetrahydrofuran for 0.666667 h; Inert atmosphere; Cooling with ice
Stage #2: With iodine In tetrahydrofuran at 20℃; for 14.5833 h;
R. Synthesis of (6S)-6-[2-fluoro-4'-(trifluoromethoxy)[1,1'-biphenyl]-4-yl]methoxy}-2-nitro-6,7-dihydro-5H-imidazo[2,1-6][1,3]oxazine (15) by the method of Scheme 11 A suspension of 4-bromo-3-fluorobenzoic acid (84) (1.61 g, 7.35 mmol) in anhydrous THF (10 mL, then 4.x.3 mL to rinse) under N2 was added drop-wise (over 40 min) to a suspension of sodium borohydride (400 mg, 10.6 mmol) in anhydrous THF (15 mL) under N2, and then the mixture was cooled in an ice bath. A solution of iodine (1.008 g, 3.97 mmol) in anhydrous THF (10 mL, then 2.x.3 mL) was added drop-wise (over 35 min) to the stirred solution and then the mixture was stirred at room temperature for 14 h. The mixture was concentrated under reduced pressure and then treated successively with water (20 mL), 10percent HCl (3.4 mL) and water (20 mL), and extracted with CH2Cl2 (4.x.50 mL). The extracts were evaporated to dryness and the residue was chromatographed on silica gel, eluting with 50percent CH2Cl2/petroleum ether, to give (4-bromo-3-fluorophenyl)methanol (85) (1.096 g, 73percent) as a white solid: mp (CH2Cl2/petroleum ether) 39-40° C.; 1H NMR (CDCl3) δ 7.52 (dd, J=8.0, 7.2 Hz, 1H), 7.16 (dd, J=9.3, 1.8 Hz, 1H), 7.02 (dd, J=8.2, 1.8 Hz, 1H), 4.67 (d, J=5.9 Hz, 2H), 1.75 (t, J=5.9 Hz, 1H); HREIMS calcd for C7H6BrFO m/z (M+) 205.9567, 203.9586, found 205.9566, 203.9580.

Reference: [1] Journal of Medicinal Chemistry, 2014, vol. 57, # 21, p. 9096 - 9104
[2] Journal of Medicinal Chemistry, 2003, vol. 46, # 14, p. 2973 - 2984
[3] Synlett, 2014, vol. 25, # 1, p. 123 - 127
[4] European Journal of Medicinal Chemistry, 2018, vol. 150, p. 506 - 524
[5] Bioorganic and Medicinal Chemistry Letters, 2001, vol. 11, # 10, p. 1257 - 1260
[6] Patent: WO2014/140279, 2014, A1, . Location in patent: Page/Page column 83; 161; 162
[7] Patent: WO2012/173917, 2012, A1, . Location in patent: Page/Page column 51
[8] Patent: WO2014/52379, 2014, A1, . Location in patent: Page/Page column 48
[9] Patent: WO2011/21209, 2011, A1, . Location in patent: Page/Page column 38
[10] Patent: US2012/101099, 2012, A1, . Location in patent: Page/Page column 13; 14
[11] Patent: WO2011/14774, 2011, A1, . Location in patent: Page/Page column 40; 41
[12] Patent: US2012/28973, 2012, A1, . Location in patent: Page/Page column 16
[13] Patent: US2003/220241, 2003, A1,
[14] Patent: US2002/49217, 2002, A1,
[15] Patent: US2002/99007, 2002, A1,
[16] Patent: US6350755, 2002, B1,
[17] Patent: US6413964, 2002, B1,
[18] Patent: US6358985, 2002, B1,
[19] Patent: US6562823, 2003, B1,
[20] Patent: US6297239, 2001, B1,
[21] Patent: US2016/24060, 2016, A1,
  • 4
  • [ 133059-43-5 ]
  • [ 222978-01-0 ]
YieldReaction ConditionsOperation in experiment
97%
Stage #1: With sodium tetrahydroborate In methanol at 0 - 20℃; for 2 h;
Stage #2: With hydrogenchloride In methanol; water
Step i :Solid NaBH4 (603 mg, 15.9 mmol) is added to a solution of ketone 50a (4.11 g, 19.92 mmol) dissolved in MeOH (62 mL) at O0C. The reaction is warmed to RT and is allowed to stir for 2 h. The reaction is quenched with aqueous HCI (1 N, 20 mL), the MeOH is removed by concentration and the product extracted with EtOAc (2 x 50 <n="111"/>mL). The organic layer is washed with brine (50 ml_), dried over MgSO4, filtered and concentrated to afford alcohol 50b (4.1 g, 97percent yield). This material is used as is in the next step.
97% With sodium tetrahydroborate In methanol at 0 - 25℃; for 2 h; Solid NaBH4 (603 mg, 15.9 mmol) is added to a solution of aldehyde 48a (4.1 1 g,19.92 mmol) dissolved in MeOH (62 mL) at O0C. The reaction is warmed to RT and is allowed to stir for 2 h. The reaction is quenched with aqueous HCI (1 N, 20 mL), the MeOH is removed by concentration and the product extracted with EtOAc (2 x 50 mL). The organic layer is washed with brine (50 mL), dried over MgSO4, filtered and concentrated to afford alcohol 48b (4 1 g, 97percent yield). This material is used as is in the next step.
97% With methanol; sodium tetrahydroborate In tetrahydrofuran To a solution of 4-bromo-3-fluorobenzaldehyde (10 g, 49.3 mmol) and NaBH4 (3.73 g, 99 mmol) in THF (100 mL) was added MeOH (100 mL) dropwise at 20° C. After LCMS analysis showed the starting material had disappeared, the solvent was removed in vacuo. The residue was dissolved in DCM (200 mL) and washed with H2O (60 mL) and brine (60 mL). The organic layer was dried over Na2SO4, filtered and concentrated to yield a white solid of (4-bromo-3-fluorophenyl)methanol (9.8 g, 47.7 mmol, 97.0percent yield): 1H NMR (400 MHz, CD3OD) δ 7.54 (t, J=7.8 Hz, 1H), 7.18 (d, J=9.6 Hz, 1H), 7.06 (d, J=7.2 Hz, 1H), 4.56 (s, 2H); ES-LCMS m/z 188.9 (M-17).
97% With sodium tetrahydroborate In tetrahydrofuran; methanol at 20℃; To a solution of 4-bromo-3-fluorobenzaldehyde (10 g, 49.3 mmol) and NaBH4 (3.73 g, 99 mmol) in THF (100 mL) was added MeOH (100 inL) dropwise at 20 °C. After LCMS analysis showed the starting material had disappeared, the solvent was removed in vacuo. The residue was dissolved in DCM (200 mL) and washed with H20 (60 mL) and brine (60 mL). The organic layer was dried over Na2S04, filtered and concentrated to yield a white solid of (4-bromo-3- fluorophenyl)methanol (9.8 g, 47.7 mmol, 97.0percent yield): lH NMR (400 MHz, CD3OD) δ 7.54 (t, J = 7.8 Hz, 1H), 7.18 (d, J = 9.6 Hz, 1H), 7.06 (d, J = 7.2 Hz, 1H), 4.56 (s, 2H); ES-LCMS m/z 188.9 (M-17).

Reference: [1] Patent: WO2009/62285, 2009, A1, . Location in patent: Page/Page column 109-110
[2] Patent: WO2009/62288, 2009, A1, . Location in patent: Page/Page column 112
[3] Patent: US2014/275111, 2014, A1, . Location in patent: Paragraph 0343; 0344
[4] Patent: WO2014/141187, 2014, A1, . Location in patent: Page/Page column 75
[5] Patent: WO2015/103317, 2015, A1, . Location in patent: Page/Page column 297
[6] Patent: WO2015/176267, 2015, A1, . Location in patent: Page/Page column 133
  • 5
  • [ 849758-12-9 ]
  • [ 222978-01-0 ]
YieldReaction ConditionsOperation in experiment
92% With diisobutylaluminium hydride In tetrahydrofuran at 20℃; To a solution of 4-bromo-3-fluoro-benzoic acid methyl ester (5.3 g, 22.9 mmol) in dry THF (60 mL) was added diisobutylaluminum hydride (30 mL) dropwise, This mixture was stirred overnight at room temperature until the starting material had been consumed, quenched with saturated aqueous potassium tartrate solution and extracted with ethyl acetate (3.x.50 mL). The combined organic layer was washed with brine, dried with Na2SO4, filtered, and evaporated to give white solid product (4.3 g, 92percent).
Reference: [1] Journal of Medicinal Chemistry, 2011, vol. 54, # 20, p. 7299 - 7317
[2] Patent: US2010/216806, 2010, A1, . Location in patent: Page/Page column 103
[3] Patent: WO2010/92043, 2010, A1, . Location in patent: Page/Page column 62
  • 6
  • [ 133059-43-5 ]
  • [ 222978-01-0 ]
Reference: [1] Patent: WO2005/56529, 2005, A1, . Location in patent: Page/Page column 36-37
[2] Patent: WO2006/133559, 2006, A1, . Location in patent: Page/Page column 29
  • 7
  • [ 452-74-4 ]
  • [ 222978-01-0 ]
Reference: [1] Journal of Medicinal Chemistry, 2003, vol. 46, # 14, p. 2973 - 2984
[2] Bioorganic and Medicinal Chemistry Letters, 2001, vol. 11, # 10, p. 1257 - 1260
[3] Patent: WO2011/21209, 2011, A1,
[4] Patent: US2012/101099, 2012, A1,
[5] Patent: WO2006/133559, 2006, A1,
  • 8
  • [ 127425-73-4 ]
  • [ 222978-01-0 ]
Reference: [1] Patent: WO2006/133559, 2006, A1,
  • 9
  • [ 557-21-1 ]
  • [ 222978-01-0 ]
  • [ 222978-02-1 ]
Reference: [1] Journal of Medicinal Chemistry, 2003, vol. 46, # 14, p. 2973 - 2984
[2] Bioorganic and Medicinal Chemistry Letters, 2001, vol. 11, # 10, p. 1257 - 1260
  • 10
  • [ 222978-01-0 ]
  • [ 222978-02-1 ]
Reference: [1] Patent: US2003/220241, 2003, A1,
[2] Patent: US2002/99007, 2002, A1,
[3] Patent: US2002/49217, 2002, A1,
[4] Patent: US6350755, 2002, B1,
[5] Patent: US6413964, 2002, B1,
[6] Patent: US6358985, 2002, B1,
[7] Patent: US6297239, 2001, B1,
  • 11
  • [ 222978-01-0 ]
  • [ 222978-02-1 ]
Reference: [1] Patent: US6562823, 2003, B1,
  • 12
  • [ 222978-01-0 ]
  • [ 101048-76-4 ]
Reference: [1] Journal of Medicinal Chemistry, 2003, vol. 46, # 14, p. 2973 - 2984
  • 13
  • [ 222978-01-0 ]
  • [ 133059-43-5 ]
YieldReaction ConditionsOperation in experiment
55% With manganese(IV) oxide In chloroform at 20℃; To a solution of (4-bromo-3-fluoro-phenyl)-methanol (4.3 g, 21 mmol) in CHCl3 (50 mL) was added manganese dioxide (18.7 g, 210 mmol), and the resulting mixture was stirred overnight at room temperature until the starting material had been consumed. After filtration, the filtrate was concentrated in vacuo to give product (2.3 g, 55percent).
Reference: [1] Patent: US2010/216806, 2010, A1, . Location in patent: Page/Page column 103
[2] Patent: US6297239, 2001, B1,
  • 14
  • [ 222978-01-0 ]
  • [ 133059-43-5 ]
Reference: [1] Patent: US6284755, 2001, B1,
  • 15
  • [ 222978-01-0 ]
  • [ 127425-73-4 ]
YieldReaction ConditionsOperation in experiment
61.1% With phosphorus tribromide In dichloromethane at 20℃; To a solution of (4-bromo-3-fluorophenyl)methanol (5 g, 24.39 mmol) in DCM (100 mL) was added PBr3 (2.76 mL, 29.3 mmol) dropwise. The resulting mixture was stirred at 20° C. After LCMS analysis showed the starting material had disappeared, the mixture was adjusted to pH=8 by aq Na2CO3. The organic layer was dried and concentrated to give the crude product, which was purified by column chromatography (PE/EA=10/1) to yield a white solid of 1-bromo-4-(bromomethyl)-2-fluorobenzene (4.2 g, 14.89 mmol, 61.1percent yield): 1H NMR (400 MHz, CD3OD) δ 7.57 (d, J=7.6 Hz, 1H), 7.28 (d, J=7.2 Hz, 1H), 7.16 (d, J=6.4 Hz, 1H), 4.53 (s, 2H); ES-LCMS m/z 186.9 (M-79).
61.1% With phosphorus tribromide In dichloromethane at 20℃; To a solution of (4-bromo-3-fluorophenyl)methanol (5 g, 24.39 mmol) in DCM (100 mL) was added PBr3 (2.76 mL, 29.3 mmol) dropwise. The resulting mixture was stirred at 20 °C. After LCMS analysis showed the starting material had disappeared, the mixture was adjusted to pH = 8 by aqueous Na2CC>3. The organic layer was dried and concentrated to give the crude product, which was purified by column chromatography (PE/EA = 10/1) to yield a white solid of 1-bromo- 4-(bromomethyl)-2-fluorobenzene (4.2 g, 14.89 mmol, 61.1percent yield): l NMR (400 MHz, CD3OD) δ 7.57 (d, J= 7.6 Hz, 1H), 7.28 (d, J= 7.2 Hz, 1H), 7.16 (d, J= 6.4 Hz, 1H), 4.53 (s, 2H); ES-LCMS m/z 186.9 (M-79).
Reference: [1] Patent: US2014/275111, 2014, A1, . Location in patent: Paragraph 0345; 0346
[2] Patent: WO2014/141187, 2014, A1, . Location in patent: Page/Page column 75
[3] Patent: WO2015/176267, 2015, A1, . Location in patent: Page/Page column 133
[4] Patent: WO2006/109633, 2006, A1, . Location in patent: Page/Page column 159
  • 16
  • [ 143-33-9 ]
  • [ 222978-01-0 ]
  • [ 499983-13-0 ]
Reference: [1] Patent: WO2005/56529, 2005, A1, . Location in patent: Page/Page column 37
  • 17
  • [ 222978-01-0 ]
  • [ 499983-13-0 ]
Reference: [1] Patent: US2014/275111, 2014, A1,
[2] Patent: WO2014/141187, 2014, A1,
[3] Patent: WO2015/176267, 2015, A1,
[4] Patent: WO2015/176267, 2015, A1,
[5] Patent: WO2006/133559, 2006, A1,
  • 18
  • [ 222978-01-0 ]
  • [ 942282-40-8 ]
Reference: [1] Patent: US2014/275111, 2014, A1,
[2] Patent: WO2014/141187, 2014, A1,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 222978-01-0 ]

Fluorinated Building Blocks

Chemical Structure| 261723-32-4

[ 261723-32-4 ]

(3-Bromo-2-fluorophenyl)methanol

Similarity: 0.93

Chemical Structure| 202865-66-5

[ 202865-66-5 ]

(2-Bromo-5-fluorophenyl)methanol

Similarity: 0.93

Chemical Structure| 216755-56-5

[ 216755-56-5 ]

(3-Bromo-5-fluorophenyl)methanol

Similarity: 0.89

Chemical Structure| 229027-89-8

[ 229027-89-8 ]

2-Bromo-4-fluorobenzyl Alcohol

Similarity: 0.89

Chemical Structure| 452-74-4

[ 452-74-4 ]

1-Bromo-2-fluoro-4-methylbenzene

Similarity: 0.86

Aryls

Chemical Structure| 261723-32-4

[ 261723-32-4 ]

(3-Bromo-2-fluorophenyl)methanol

Similarity: 0.93

Chemical Structure| 202865-66-5

[ 202865-66-5 ]

(2-Bromo-5-fluorophenyl)methanol

Similarity: 0.93

Chemical Structure| 216755-56-5

[ 216755-56-5 ]

(3-Bromo-5-fluorophenyl)methanol

Similarity: 0.89

Chemical Structure| 229027-89-8

[ 229027-89-8 ]

2-Bromo-4-fluorobenzyl Alcohol

Similarity: 0.89

Chemical Structure| 452-74-4

[ 452-74-4 ]

1-Bromo-2-fluoro-4-methylbenzene

Similarity: 0.86

Bromides

Chemical Structure| 261723-32-4

[ 261723-32-4 ]

(3-Bromo-2-fluorophenyl)methanol

Similarity: 0.93

Chemical Structure| 202865-66-5

[ 202865-66-5 ]

(2-Bromo-5-fluorophenyl)methanol

Similarity: 0.93

Chemical Structure| 216755-56-5

[ 216755-56-5 ]

(3-Bromo-5-fluorophenyl)methanol

Similarity: 0.89

Chemical Structure| 229027-89-8

[ 229027-89-8 ]

2-Bromo-4-fluorobenzyl Alcohol

Similarity: 0.89

Chemical Structure| 452-74-4

[ 452-74-4 ]

1-Bromo-2-fluoro-4-methylbenzene

Similarity: 0.86

Alcohols

Chemical Structure| 261723-32-4

[ 261723-32-4 ]

(3-Bromo-2-fluorophenyl)methanol

Similarity: 0.93

Chemical Structure| 202865-66-5

[ 202865-66-5 ]

(2-Bromo-5-fluorophenyl)methanol

Similarity: 0.93

Chemical Structure| 216755-56-5

[ 216755-56-5 ]

(3-Bromo-5-fluorophenyl)methanol

Similarity: 0.89

Chemical Structure| 229027-89-8

[ 229027-89-8 ]

2-Bromo-4-fluorobenzyl Alcohol

Similarity: 0.89

Chemical Structure| 99725-13-0

[ 99725-13-0 ]

(5-Bromo-2-fluorophenyl)methanol

Similarity: 0.85